Vaccines
| Indication | rePAXTM: Lead Generation | rePAXTM: Lead Optimization / POC | Preclinical Development | |
| Infection | Influenza |  |
||
| Infection / Oncology | HPV (partnered) |  |
||
| Infection | CMV |   |
||
Designer VLPs can be used as vaccine candidates for enveloped and non-enveloped viral targets (e.g. RSV, HCV, Dengue, etc.) and add-ons.